Los puntos clave no están disponibles para este artículo en este momento.
CYD0682 attenuates endogenous and TGFβ-induced STAT3 activation and ECM production via an HSP90 dependent pathway in HSCs. Further study of this pathway may present new targets for therapeutic intervention in hepatic fibrosis.
Cheung et al. (Sun,) studied this question.